Medicine Overview of Telmikaa AMH Tablet
Nausea, Altered taste, Stomach upset, Headache, Flushing (sense of warmth in the face, ears, neck and trunk), Dizziness, Increased blood uric acid, Numbness of extremity, Flushing of skin, Increased blood lipid level, Decreased sodium level in blood, Decreased magnesium level in blood, Decreased blood pressure.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Telmikaa AMH Tablet may be taken with or without food, but it is better to take it at a fixed time.
Telmikaa AMH Tablet is a combination of three medicines: Telmisartan, Amlodipine and Hydrochlorothiazide. Telmisartan is an angiotensin receptor blocker (ARB) and Amlodipine is a calcium channel blocker (CCB). They work by widening and relaxing the blood vessels, thereby lowering blood pressure. Hydrochlorothiazide is a diuretic which removes extra water and certain electrolytes from the body through urine. Over time it also works by relaxing blood vessels and improving blood flow.
In Depth Information on Telmikaa AMH Tablet
Telmikaa AMH Tablet related warnings
Taking Hydrochlorothiazide with alcohol may have additive effects in lowering blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Telmikaa AMH Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Telmikaa AMH Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Telmikaa AMH Tablet may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Telmikaa AMH Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Telmikaa AMH Tablet may be needed. Please consult your doctor.
Use of Telmikaa AMH Tablet is not recommended in patients with severe kidney disease.
Telmikaa AMH Tablet should be used with caution in patients with liver disease. Dose adjustment of Telmikaa AMH Tablet may be needed. Please consult your doctor.
No Patient Concerns found for this medicine
User Submitted Feedback For Telmikaa AMH Tablet
Patients taking Telmikaa AMH Tablet How much was the improvement? What are you using Telmikaa AMH Tablet for?
Survey Participants: 4
“The following are the results of on-going survey on 1mg.com for Telmikaa AMH Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Telmikaa AMH Tablet: MDO, DGN, HEX, PEN, OIP, SAF, DLP, MLC, ATP, OWP, AYM, RHL, PNT, EVP, WHL, TFP, GBL, SBL, MMS, AAR, STA, RSS, CLT, VDH, 9T9, MAK, MDH, JVN, GHR, GTK, SGH, RKS, QTM, BMJ, KHH, BAL, NNH, SRG, RUS, ESY, INC, SHD, HAT, DFP, PLT, HIP, SWP, HTS, EMB, BAP, SJP, AYU, KHC, ENP, SYN, RJH, ZEL, DPL, GPT, RSA, HGI, DPP, TRP, TNH, BDN, SBA, JSL, ARD, RWP, SLN, SWA, JIV, ABP, IAD, VNS, AAY, GPP, RDR, KMC, ATL, HBV, MSD, HNP, ZVP, NXG, SGC, LCC, BHM, PMA, DVH, GNC, BIO, PPR, JVO, BSN, UMP, PTI, BHP, HPC, FGH, NVL, SCH, PWN, OHM, HMP, SHP, GTC, OLT, PVP, LHA, RPP, RHW, MAM, DHR, DYG, NDP, USF, NTB, AGT, P2P, SHC, NVY, ANT, HSP, EQN, THP, SDM, TOM, NSL, BTM, ADT, HZF, SVH, AMR, PRN, BLE, IPL, RPI, WSI, SSA, VRS, QLF, MAX, MPC, BBS, RDH